PTPN11 mutations are most commonly associated with Noonan syndrome and juvenile myelomonocytic leukemia; however, activating somatic mutations have been observed in solid tumors, including colorectal, breast, and renal cell carcinomas [20, 21]. The gene discussed is PTPN11; the disease is juvenile myelomonocytic leukemia.